New Website And Samples Of Advanced Natural Non-Prescription Medicines Announced by OLFC

Olfactory Biosciences’s new website offers bio similar non-prescription natural medicines. They are nasal gels applied for relief of common conditions such as sensory issues, food cravings and binging, stress and anxiety, memory and concentration and sleep issues https://www.noxoinfo.com

PHILADELPHIA, PA / ACCESSWIRE / September 30, 2015 / Olfactory Biosciences Corp. (PINKSHEETS: OLFC) launched its new website featuring new products with natural ingredients, using advanced Olfaction and chemoreception. Medicine delivery is just rubbing a small amount of the gel to the end of the nostrils. Free samples of the top products are offered on product website pages. https://www.noxoinfo.com

“Our new natural bio similar medicines are years ahead of equivalent prescription medicines,” said Richard Stevenson, President

The new lineup includes : HungerMgmt(TM) to Curb your Cravings and Binging: Sensopath(TM) for Relief from sensory issues : Exanstres(TM) for Stress Relief the Natural Way : Somaklin(TM) for Instant Relief from Anxiety : Sambigan(TM) for Natural Sleep without Pills : Nootravate(TM) to Enhance yourMemory : Studibuddy(TM) for Peak Memory and Concentration : Emoodal(TM) a good way to Change to the best Mood and NOXO Odor Defense Pro(TM) the unique product where the smell might be there but you won’t smell it.

For more information go to https://www.noxoinfo.com

About Olfactory Biosciences Corp.

Olfactory Biosciences Corp. continues to lead the field of advanced natural medicines with unique external delivery systems. The company develops topical medicine products can modify behavior or provide relief to common behavior challenges.

FORWARD-LOOKING STATEMENTS

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company’s business. and Exchange Commission (SEC) filings under “risk factors” and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Contact:

Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Phone: 484-278-1626
Website: https://www.noxoinfo.com/
Email: support@noxoinfo.com

SOURCE: Olfactory Biosciences Corp.

ReleaseID: 432319